Generalized Myasthenia Gravis
Also known as: Myasthenia Gravis, Generalized / Myasthenia Gravis Generalised
|A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
|A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive.
|Hyaluronidase (human recombinant)
|An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.
|A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
|A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis.
|A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults.